Does Rivaroxaban Better than Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing PCI?
Crossref DOI link: https://doi.org/10.17352/ahcrr.000003
Published Online: 2016-12-30
Update policy: https://doi.org/10.17352/crossmark-policy
Kara, M
Aitmokhtar, O
Azaza, A
Seddiki, S
Harbi, F
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2015-05-25